Therapeutics News

Model silicone hydrogel materials prepared with atropine and roscovitine to treat myopia and retinoblastoma may eliminate the need for regular drop instillation and allow for the drug concentration to be maintained in the tear film, according to Lasowski and colleagues in Optometry and Vision Science.

Women aged 40 years or older who used oral contraceptives may have an increased risk of self-reported glaucoma or ocular hypertension, according to a study.

ATLANTA – The new ophthalmic division of Sun Pharma intends to enter the marketplace with several new products within the next 12 months and a focus on its relationships with professionals.

ATLANTA – An Alcon executive explained the company’s plans to separate its medical device and pharmaceutical businesses, during a company-sponsored press conference here at SECO.

ATLANTA – Agustin L. Gonzalez, OD, FAAO, said the results of the Antibiotic Resistance Monitoring in Ocular Microorganisms (ARMOR) study indicate that the incidence of methicillin-resistant Staphylococcus aureus and resistance to Pseudomonas are on the rise.

High-dose, moderate-dose and low-dose atropine showed the best control of myopia progression, according to a study recently published in Ophthalmology.

The associations between visual acuity and morphologic features on fundus photography, fluorescein angiography and optical coherence tomography in the second year of the Comparison of Age-related Macular Degeneration Treatment Trials were maintained or strengthened during year 2, according to researchers in Ophthalmology.

Total spending on prescription medications in the U.S. increased 10.3% on a real per capita basis to $373.9 billion in 2014, according to a report from the IMS Institute for Healthcare Informatics.

Pfizer announced in a press release its executive leadership team for the combined Pfizer and Allergan business following the close of the proposed merger of the companies.

Thousands of physicians from American safety-net hospitals signed a letter sent to Congress highlighting the importance of the 340B Drug Pricing Program.